PRESS RELEASES
2022-09-22 21:00
Lipum has resolved on a directed share issue of approximately SEK 39 million at a subscription price of SEK 14.99 per share
The Directed Share Issue comprises 2,601,732 new shares issued at a subscription price of SEK 14.99 per share, which means that the Company will raise...
2022-08-09 08:45
Lipum to participate in upcoming industry meetings
LSX Nordic, Copenhagen, Denmark, 6-7 September Biostock Investerarevent, digital, 14 September Nordic Life Science Days, Malmö, Sweden, 28-29 September...
2022-07-27 08:00
Lipum AB - interim report for the period January - June 2021
CEO Einar Pontén comments: “Through long-term and systematic work, we are now almost ready to start clinical trials. We have mitigated many...
2022-07-08 08:30
Lipum has recruited Helena Bergström as Chief Medical Officer
Dr. Helena Bergström is an experienced clinician that previously also has been involved in research of sex-and gender differences in medicine, drug...
The non-clinical program for toxicology- and safety studies of Lipum’s candidate drug (SOL-116) has been carried out in collaboration with the contract...
2022-05-25 11:30
Lipum participates at Redeye Growth Day 2022
Redeye Growth Day takes place on June 2 in Stockholm and will be a combination of a digital platform and live presentations. Lipum is "In Focus"...
2022-05-18 08:30
Lipum AB – interim report for the period January-March 2022
CEO Einar Pontén comments: “More progress was made in the preparations ahead of clinical trials. In parallel, and in accordance with our strategy...
2022-05-13 13:15
Lipum initiates collaboration with Pelago Bioscience
Pelago Bioscience AB is a fast-growing Swedish company, based in Solna, with bioanalytical expertise and services for drug discovery and development. Pelago...
2022-05-05 17:10
Lipum in consortium being granted research funding by KKS
Lipum is member of the consortium together with both industry and academic partners. The project is led by the Cardiovascular Research Centre (CVRC) at...
2022-04-07 09:00
Lipum abstract accepted for EULAR 2022
The aim of Annual European Congress of Rheumatology EULAR 2022 is to provide a forum of the highest standard for scientific (both clinical and basic)...